INTRODUCTION
Chronic rhinosinusitis (CRS) is a common inflammatory disease that is characterized by nasal obstruction, olfactory dysfunction, nasal discharge, and tension pain that persist over 3 months.
1,2 CRS with nasal polyposis (CRSwNP) is a distinct diagnostic and therapeutic entity with unclarified etiopathogenesis. 1, 2 CRSwNP is currently considered as an immunological disease that is affected by immunological disorders, environmental factors, Staphylococcus superantigens, fungal infections, and the presence of microbial biofilms. [1] [2] [3] Biofilm creates a special environment for microbial survival and proliferation that consists of a self-produced, three-dimensional extracellular matrix formed by polysaccharides, proteins, nucleic acids, and water. [4] [5] [6] Microbial biofilms are characterized by extremely high resistance against antibiotics, host immune reactions, and chemical and physical agents. [3] [4] [5] This strong and continuously remodeled physical barrier blocks the diffusion of antibiotics, superoxides, immunoglobulins, and opsonins. 3, 5, 6 Biofilms and consecutive inflammatory reactions might contribute to the epithelial damage and subsequent hyperplasia of the subepithelial layer, resulting in nasal polyp formation. [6] [7] [8] [9] Persisting biofilms in CRSwNP may be responsible for surgical failures and high recurrence rate of disease. 1, 6, 7 Because biofilms are supposed to play an important role in the pathogenesis of CRSwNP, several therapeutic protocols targeting these structures have been reported and tested in recent years. 1, 2, 10 Long-term and low-dose macrolide antibiotic therapy has been supposed to have therapeutic advantages in the elimination of bacterial biofilms in CRSwNP. 11, 12 Beyond the bacteriostatic effects, macrolides have a potential role in the modulation of immune response and consecutive tissue reactions. [12] [13] [14] However, there are conflicting results. In the MACS study (Macrolides in Chronic Rhinosinusitis), low-dose and long-term application of azithromycin did not have any advantages against placebo between clinical conditions. 15 Because microbial biofilms are characterized by strong negative electrical charge, cationic detergents may have beneficial effects in biofilm disruption. 16 It has been reported that 1% baby shampoo has no effects on preformed biofilms; however, it may prevent biofilm formation after endoscopic sinus surgery (ESS) of patients with CRSwNP.
In the light of these results, more research is required to investigate the effectiveness of macrolide and cationic detergent therapy against biofilms in CRSwNP.
There is increasing evidence that continuous-(CUS) or pulsed-wave (PUS) low-frequency ultrasound (LFU) treatment is a reliable and safe method for biofilm removal in CRSwNP. 10, [17] [18] [19] Bartley and Young discussed that intranasal application of therapeutic ultrasound may increase the sensitivity against antibiotics due to the physical fragmentation of compact biofilm barriers. 17 Preoperative application of LFU treatment may increase the surgical success rates with decreased frequency of repeated surgeries due to recurring disease. 17 Young et al. treated 22 CRSwNP patients by 1 MHz pulsed-wave ultrasound 2 to 3 days a week for six sessions. 18 In contrast to the extranasal application of LFU treatment, the authors have reported a significant improvement of sinusitis symptoms in 18 patients according to the decreased values of Sino-Nasal Outcome Test questionnaire. 18 Later, Ansari et al. reported a significant difference between the effectiveness of pulsedwave (PUS) and continuous-wave (CUS) ultrasound therapy in CRS. 20 The authors found a greater improvement of sinusitis-associated symptoms in the PUS-treated patient group. 20 In a preliminary study on cadaver heads, Patel et al. demonstrated that LFU treatment is a safe protocol that was confirmed by histopathological analysis of the ultrasound-treated nasal mucosa. 19 This research group also demonstrated that LFU treatment may promote the delivery of various topical solutions in the nasal cavity, except for the frontal sinus. 19 This preliminary study investigates the effectiveness and microscopic safety of low-frequency continuouswave ultrasound treatment in biofilm disruption in chronic rhinosinusitis with nasal polyposis between in vitro conditions.
MATERIALS AND METHODS

Patients
A case-control experimental study was performed on nasal polyp specimens obtained from patients with CRSwNP who underwent ESS at the Department of Otorhinolaryngology and Head and Neck Surgery, University of Debrecen. Nasal polyps (n ¼ 20) were collected between January 2012 and April 2012. The patient group consisted of four males and six females (n ¼ 10, mean age, 51.3 years; range, 32-61 years) with the diagnosis of CRSwNP confirmed by nasal endoscopy and computed tomography (CT) scans of the paranasal sinuses. All the nasal polyps collected during ESS were divided into two consecutive groups consisting of 10-10 specimens that were processed to histopathological analysis alone and LFU treatment, respectively. Only nasal polyps larger than 2 cm were analyzed, which could be removed by straight endoscopic forceps without any surface injury or iatrogenic disruption of biofilm layers. The removal was gently performed at the root of the nasal polyps. All patients gave their informed consent before donating their tissue samples for the study. The institutional ethical committee approved our study. The study was carried out according to the Declaration of Helsinki.
Hematoxylin-Eosin and Gram Staining
According to previous reports, a combination of hematoxylin-eosin (HE) and Gram staining protocols seems to be a usable method for the detection of biofilm existence and corresponding histopathological changes, because HE staining is for the investigation of microscopic architecture, whereas Gram protocol stains various microbial elements. 21, 22 The first series of 10 LFU-untreated nasal polyps were fixed in 10% (w/v) formaldehyde. Specimens were embedded in 15% (w/v) purified gelatin (24 hours, 56 C) and refixed in 4% (w/v) paraformaldehyde (24 hours, 20 C). Blocks were cryoprotected in 20% (w/v) sucrose solution (2 hours, 4 C) and sectioned into 5-lm slides at À25 C (MNT-200; Slee, Mainz, Germany). Slides were stored in 0.1 M phosphate-buffered saline containing 0.03% (w/v) sodium azide at 4 C. Two consecutive 5-lm frozen-cut sections were examined as follows: 1) conventional staining with HE, and 2) conventional Gram staining. The criteria for the histopathological detection of microbial biofilms were the presence of characteristic morphology and Gram positivity/negativity and microcolonies for examination by optical microscopy and the presence of the surrounding polysaccharide layer. 22 Structure and cellular infiltration of the epithelial and also the subepithelial layers were correlated to the presence of bacterial biofilms.
In Vitro LFU Treatment
The second series of nasal polyps were placed into 0.9% (w/v) sodium chloride solution immediately after surgical removal. LFU treatment protocol was started within 30 minutes after tissue sampling (Sonica 5200-EP; Soltec, Milan, Italy). Nasal polyp specimens were placed into a self-designed silicone vat. LFU treatment with 0.4 MHz frequency and 0.5 W/cm 2 sound pressure was employed for 5 minutes at 37 C in 20 mL total volume of 0.9% (w/v) sodium chloride solution. A digital thermometer was applied to register any temperature changes during the protocol. Ultrasound-treated nasal polyps were fixed in 10% (w/v) formaldehyde and then the same histopathological staining protocols were performed that were previously described. Histopathological characteristics of biofilms, and epithelial and subepithelial layers of untreated specimens were correlated to ultrasound-treated identical nasal polyp pairs with the aim of analyzing the effects of therapeutic ultrasound on biofilms and microscopic structures. Statistical assessments were performed by Mann-Whitney U probe with a 95% confidence interval (SPSS 9.0 for Windows; SPSS, Inc. Chicago, IL). Histological pretreatment protocols were performed by an independent laboratory assistant in all cases. Both sets of histological examinations in the LFU-treated and untreated sample groups were independently analyzed by two researchers (P.C. and T.K.).
RESULTS
Altogether, 10 patients with CRSwNP who underwent ESS were included in this study. The LundMackay scores of coronal reconstructed CT scans varied between 15 and 24 with an average score of 21, indicating serious involvement of paranasal sinuses by CRS. The score was higher than 21 in 70% of patients (n ¼ 7). The clinical history and findings of physical examinations were obtained during confirmation of the diagnosis of CRSwNP. Clinical information on bronchial asthma, allergic rhinitis, aspirin intolerance, previous ESS, topical steroid treatment, and systemic antimicrobial therapy was recorded before surgery. Three patients (30%) had bronchial asthma, 10% (n ¼ 1) had allergic rhinitis, and 10% (n ¼ 1) had the diagnosis of aspirin intolerance. This patient had complete acetylsalicylic acid triad (nasal polyposis, bronchial asthma, and aspirin intolerance). Diagnosis of allergic rhinitis was based on the clinical history, on the physical examination, and on the allergen-specific intracutaneous (prick) skin test. Inhalative allergen-specific serum immunoglobulin G levels were also measured by enzyme-linked immunosorbent assay in all cases. The diagnosis of bronchial asthma was based on the clinical history and on the respiratory functional test. The final diagnosis was stated by an experienced pulmonologist in all cases. Aspirin (within 6 weeks), systemic antibiotic treatment (cefuroxime) was performed in one (10%) patient due to acute rhinosinusitis. The histopathological examination revealed inflammatory nasal polyps with polymorphonuclear and plasmocyte infiltration of the subepithelial layer in all cases (Fig.  F1  1) . Disintegrated epithelial layer with partial squamous cell metaplasia was found in seven cases (n ¼ 7, 70%), whereas in three nasal polyps (n ¼ 3, 30%) the epithelium showed normal architecture with ciliated columnar and foamy cells (Fig. 1) . Bacterial biofilms were detected in all patients with CRSwNP ( Figs. 1 and  F2 2, Table  T1 I). In our series, HE staining displayed a strong correlation with the results of Gram staining and was found to be a reliable predictor of the presence or absence of biofilms. In the LFU-untreated group, thickness of biofilm layer varied between 9.24 to 22.53 lm, with the average of 17.3 lm (Table I ). In the LFU-treated group of nasal polyps, combined application of HE and Gram-staining protocols revealed the total absence of bacterial biofilms (P < .001) (Figs. 1 and 2 , Table I ). In the LFU-untreated nasal polyps, the stromal substance displayed a serious inflammatory cell infiltration that was predominantly formed by eosinophil and neutrophil granulocytes (Fig. 1) . In the average of 10 large magnification microscopic fields, the inflammatory cell count varied between 486 to 730.4, with the average of 603.72 cells (Fig. 1, Table I ). In the LFU-treated group, the average number of inflammatory cells decreased to 38.81, which was a statistically significant difference (P < .001) (Fig. 1, Table I ). Architectural changes due to LFU treatment were not detected in the epithelial or in the subepithelial layers of nasal polyps (Fig. 1) . In the LFUtreated group, the reticular pattern of the connective tissue web remained intact, and no signs of vascular damage, leukocyte disintegration, or karyorrhexis (leukocytoclasia) could be detected (Fig. 1) . No significant temperature changes were detected during LFU treatment (average DT was 0.34 C).
DISCUSSION
In the present study, we demonstrated the presence of biofilms in all patients with CRSwNP by the combined application of HE and Gram protocols. 22 The weakness of our study is the absence of a control group and the relatively low number of subjects, which should be increased in the future to obtain more precise statistical correlations. Although the presence of biofilm itself is supposed to be an important factor in the pathogenesis of CRSwNP, microbiological identification of different bacterial and fungal species involved in biofilm formation still requires culturing, confocal laser scanning microscopy, or fluorescent in situ hybridizations analysis with species-specific oligonucleotide probes. 4, 23 The presence of microbial biofilms is suspected to affect the intensity of subepithelial inflammatory reaction in CRSwNP. [6] [7] [8] Inflammatory cells accumulating in the subepithelial and stromal layer of nasal polyps are responsible for the uncontrolled release of several proinflammatory cytokines. 8, 9, 13 Increased expression of IL-1, tumor necrosis factor-a, receptor AQ2 activator of nuclear factor kappa-B ligand, and macrophage colony-stimulating factor may lead to epithelial disintegration and increased connective tissue formation in the stromal substance. 7, 9, 13, 14 Because biofilms might play a central role in chronic inflammation and nasal polyp formation; disruption of these microbial structures seems to be essential in the nonsurgical treatment of CRSwNP. 3, 6, 10 CUS or PUS low-frequency ultrasound treatment has been reported as a potent therapeutic option for the physical disruption of biofilms in CRSwNP. 10, 17, 18 The idea is not new and has physical evidence, because LFU is widely used for the cleaning of laboratory devices with superficial biofilm contamination. 10 Therapeutic ultrasound of 0.4 to 3.3 MHz frequencies is commonly used in the rheumatology practice and in rehabilitation medicine. In soft tissues, maximum energy absorption varies between 2 to 4 cm. Therapeutic ultrasound has various tissue effects: it increases blood flow in the treated area, decreases edematous swelling, and results in microcavitation and acoustic streaming. 19, 20 Microcavitation originates from the ultrasound-induced vibration of soft tissues that results in the formation of microscopic air bubbles, which transmit these vibrations directly to the cell membranes, vascular walls, and to biofilms. 17, 18 According to our results, LFU treatment can be supposed as a reliable and safe method for biofilm disruption in CRSwNP. It was found that the amount of inflammatory cells in the subepithelial and stromal layers showed a statistically significant decrease due to LFU treatment. Ultrasound-induced movement, intravascular microstreaming, and the escape effect of leukocytes at the surgical resection surface of nasal polyps might be responsible for this finding. At this point, it seems to be an interesting observation; however, its clinical effects are unpredictable. This unclarified phenomenon may have beneficial effects in the treatment of CRSwNP by a significant reduction of subepithelial inflammation in the nasal mucosa. On the other hand, an uncontrolled release of inflammatory cytokines and consecutive inflammatory reactions with serious rebound effects are also conceivable. Although no leukocyte destruction was found, the answer requires further research between controlled clinical conditions. According to enhanced wave reflection at tissue borders and limited penetration depth, extranasal application of LFU protocol seems to be only a symptomatic treatment in CRSwNP. 18 In the near future, intranasal application of LFU treatment will need to be tested in biofilm disruption in CRSwNP (Fig.  F3 3). To avoid sound reflection that occurs at air interfaces in the nasal cavity, a transducing medium is necessary for the ultrasound energy to be delivered to the mucosal surfaces. We do think that after intranasal upload of 0.9% (w/v) sodium chloride solution, application of a thin and special low-frequency ultrasound probe with potential temperature and sound pressure control will be a reliable method in the nonsurgical treatment of CRSwNP (Fig. 3) . Certainly, this hypothesis requires several further research and clinical studies in the future.
Corticosteroids have beneficial effects on the symptoms of CRSwNP and significantly decrease nasal obstruction and olfactory dysfunction. 1, 2, 13 On the other hand, steroid treatment may have adverse effects on biofilm presence due to the inhibition of local immune response. 13, 22 As we have concluded previously, steroid and systemic antibiotic treatment might adversely affect the structure and thickness of biofilms. 22 However, a combination of topical steroid medication, systemic antibiotic treatment, and LFU protocol may have additional beneficial effects in the nonsurgical treatment of CRSwNP. In the future, placebo-controlled, doubleblinded, multicenter studies will be necessary to prove the effectiveness of this combination of different therapeutic protocols.
CONCLUSION
This study indicates a potential therapeutic effect of LFU treatment in CRSwNP, because bacterial biofilms were completely removed in the LFU-treated group of nasal polyps. In general, therapeutic considerations can be divided into two main groups: blockade of biofilm formation and eradication of biofilms that have already formed (Fig. 3) . Although specific treatments are not yet available to target microbial biofilm, its detection and eradication is an important requirement, because it is strongly associated with treatment failures and persisting symptoms of CRSwNP. In the future, systemic double-blinded studies will be required to confirm the therapeutic effectiveness of the LFU-protocol in the nonsurgical treatment of CRSwNP. 
